http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Yasmeen Akhtar,,Mahiuddin Alamgir,,Mahmud Tareq Hassan Khan,,JMA. Hannan,M Shahabuddin Kabir Choudhuri 경희대학교 융합한의과학연구소 2007 Oriental Pharmacy and Experimental Medicine Vol.7 No.4
A well known Ayurvedic formulation Ashokarista, used for menstrual disorders has been studied in a single blind randomised placebo controlled clinical trial for the treatment of menorrhagia and dysmenorrhoea. Dysmenorrhoea and menorrhagia patients who were taking Ashokarista (20 ml twice daily) for 10 menstrual cycles had an increase in haemoglobin level. Menorrhagia treated group has shown to reduce the erythrocyte sedimentation rate level that has been increased in the menorrhagia control group. The platelet count, total count and differential count were observed unchanged in the study. The Ashokarista did not affect the SGPT and SGOT level, which signify its lack of toxicity in hepatic function. The treated menorrhagic patients showed an increase in serum albumin content and decrease in blood clotting time, whereas the serum protein content was observed unchanged. There was a significant increase in both serum cholesterol and triglyceride level, which usually associated with the use of oral contraceptives. No major side effects were observed by the clinicians during the study.
Akhtar, Yasmeen,Alamgir, Mahiuddin,Khan, Mahmud Tareq Hassan,Hannan, JMA.,Choudhuri, M Shahabuddin Kabir Kyung Hee Oriental Medicine Research Center 2007 Oriental pharmacy and experimental medicine Vol.7 No.4
A well known Ayurvedic formulation Ashokarista, used for menstrual disorders has been studied in a single blind randomised placebo controlled clinical trial for the treatment of menorrhagia and dysmenorrhoea. Dysmenorrhoea and menorrhagia patients who were taking Ashokarista (20 ml twice daily) for 10 menstrual cycles had an increase in haemoglobin level. Menorrhagia treated group has shown to reduce the erythrocyte sedimentation rate level that has been increased in the menorrhagia control group. The platelet count, total count and differential count were observed unchanged in the study. The Ashokarista did not affect the SGPT and SGOT level, which signify its lack of toxicity in hepatic function. The treated menorrhagic patients showed an increase in serum albumin content and decrease in blood clotting time, whereas the serum protein content was observed unchanged. There was a significant increase in both serum cholesterol and triglyceride level, which usually associated with the use of oral contraceptives. No major side effects were observed by the clinicians during the study.
An overview of Acne Vulgaris (Busoor Labaniya)
Mehnaz, Mehnaz,Shamsi, Yasmeen,Akhtar, Md. Wasi,Zaidi, Sahar,Mohanty, Sujata,Ahmad, Sayeed Cellmed Orthocellular Medicine and Pharmaceutical 2022 셀메드 (CellMed) Vol.12 No.2
Acne vulgaris is a common dermatological condition affecting the pilosebaceous units and having a multifactorial etiology. In Unani terminology, acne vulgaris is referred as Busoor Labaniya, characterized by white lesions on the face, nose, and cheeks; on squeezing, release cheesy material. In conventional medicine, mild cases are best addressed with topical regimens, but more severe cases require systemic medications. Retinoids (retinoic acid, adapalene, isotretinoin, tazarotene), benzoyl peroxide, clindamycin, erythromycin, and azelaic acid are a few examples of topical medications, whereas systemic drugs include antibiotics (Doxycycline, minocycline, erythromycin, azithromycin). In the Unani System of Medicine, numerous single and compound drugs have been used to treat Busoor Labaniya. These drugs are considered harmless and do not have any major side effects. In Unani system of medicine, acne vulgaris is effectively managed with natural medicines as well as therapeutic regimens with minimal side effects even after long-term usage. Acne vulgaris is usually treated with systemic blood purifiers along with topical Unani drugs. Hence, clinical studies with proper scientific parameters are needed to be conducted to establish and validate their efficacy in the prevention and control of acne vulgaris.
One for All - Artemisia absinthium (Afsanteen) "A Potent Unani Drug"
Hashimi, Ayshah,Siraj, Mantasha Binth,Ahmed, Yasmeen,Siddiqui, Md. Akhtar,Jahangir, Umar Cellmed Orthocellular Medicine and Pharmaceutical 2019 셀메드 (CellMed) Vol.9 No.4
The therapeutic use of the wormwood plant Artemisia absinthium L. dates back to at least Roman times. There are more than 200 plants in the genus Artemisia- including southern wormwood, petite wormwood and Grande wormwood and encompasses about 500 species. The best-known species of wormwood is Artemisia absinthium, native to temperate Eurasia and North Africa and is branded for its extreme bitterness. It is a magical greens booze used as carminative to support healthy appetite, balances healthy flora, cleanse the digestive tract of parasite and toxins. It possesses anti-inflammatory, immunomodulatory, hepatoprotective, anti-helminthic and anti-depressant activity. Thujone excites nervous system when taken in small amount. Due to contrary history of wormwood, its application in individuals should be preceded by a thorough and cautious risk-benefit analysis. In this appraisal an attempt is done to validate scientifically, mentioned therapeutic potential of Artemisia absinthium in classical Unani literature using PubMed, Science Direct researches.